Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BDX

King - 50 or more consecutive years of dividend increases

Max Ratio

3.96

5Y Dividend Growth

29.00 %

Consecutive Years

51 year

5Y Average Payout Ratio

68.21 %
Forward Annual Dividend Yield 2.38 %
Consecutive Years 51
Forward Annual Dividend 4.16 USD
Consistent Years 51
Dividend CAGR 3Y 5.87 %
Continuous Dividends
Dividend CAGR 5Y 5.16 %
Payout Ratio TTM 28.89 %
Dividend CAGR 10Y 5.96 %
Ex Dividend Date 09.06.2025

Becton Dickinson and Company

BDX
Current price
175.50 USD +0.5 USD (+0.29%)
Last closed 172.95 USD
Company www.bd.com
ISIN US0758871091
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NYSE
Capitalization 50 050 183 168 USD
Yield for 12 month -21.61 %
1Y
3Y
5Y
10Y
15Y
BDX
21.11.2021 - 28.11.2021

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey. Address: 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

217.83 USD

P/E Ratio

33.58

Dividend Yield

2.38 %

Financials BDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+20 178 000 000 USD

Last Year

+19 372 000 000 USD

Current Quarter

+5 272 000 000 USD

Last Quarter

+5 168 000 000 USD

Current Year

+9 125 000 000 USD

Last Year

+8 170 000 000 USD

Current Quarter

+2 257 000 000 USD

Last Quarter

+2 235 000 000 USD
EBITDA 5 573 000 192 USD
Operating Margin TTM 16.01 %
Price to Earnings 33.58
Return On Assets TTM 3.69 %
PEG Ratio 0.87
Return On Equity TTM 5.89 %
Wall Street Target Price 217.83 USD
Revenue TTM 20 867 000 320 USD
Book Value 88.07 USD
Revenue Per Share TTM
Dividend Share 3.98 USD
Quarterly Revenue Growth YOY 4.50 %
Dividend Yield 2.38 %
Gross Profit TTM 9 665 999 872 USD
Earnings per share 5.20 USD
Diluted Eps TTM 5.20 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -42.20 %
Profit Margin 7.18 %

Stock Valuation BDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 33.58
Forward PE 11.25
Enterprise Value Revenue 3.27
Price Sales TTM 2.40
Enterprise Value EBITDA 14.66
Price Book MRQ 1.96

Technical Indicators BDX

For 52 Weeks

162.35 USD 249.34 USD
50 Day MA 174.69 USD
Shares Short Prior Month 3 260 445
200 Day MA 215.34 USD
Short Ratio 1.20
Shares Short 3 213 975
Short Percent 1.12 %